Utah Medical (UTMD): Debts to Book Capitalization

This price chart for Utah Medical Products (UTMD) illustrates the performance of the neonatology and gynecology products manufacturer, whose yield reaches 0.00. Export sales and high profitability drive the business growth. The company minimizes third-party contracting by manufacturing catheters in-house, with the exception of polymer procurement. Patents and FDA certification provide a powerful moat against competitors, as clinics rarely switch from proven suppliers.

This ratio reflects the extent to which the capital structure depends on borrowed funds relative to the book value of assets, allowing for an assessment of financial risk and the efficiency of leverage utilization. By analyzing the debt-to-market capitalization chart, an investor can determine the ability of Utah Medical Products (UTMD) to finance environmental production upgrades and the implementation of safe polymers without incurring an excessive debt burden.